← Dashboard
Stock
BGLC
BioNexus Gene Lab Corp.0 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
0
27 funds tracked
Ever held
2
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
May 15, 2025Aug 14, 2025
Now
0
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q2 2025 | Q3 2025 | — | +0% |
| Two Sigma Investments | Q2 2025 | Q3 2025 | — | +0% |
Fundamentals
XBRL · BioNexus Gene Lab Corp.Annual figures sourced directly from BioNexus Gene Lab Corp.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$7.42M
FY2025-22% YoY
Net income
-$2.98M
FY2025-87% YoY
EPS (diluted)
$-0.0900
FY2024+46% YoY
Free cash flow(?)
-$1.88M
FY2025+19% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for BioNexus Gene Lab Corp — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KJun 5, 2026
- 10-QFORM 10-QMay 15, 2026
- 10-KFORM 10-KApr 14, 2026
- 8-KFORM 8-KMar 17, 2026
- 8-KFORM 8-KFeb 23, 2026
- 8-KFORM 8-KFeb 3, 2026
- 8-KFORM 8-KDec 30, 2025
- 8-KFORM 8-KDec 23, 2025
- DEF 14AProxy statementDec 3, 2025
- 8-KFORM 8-KDec 2, 2025
- 10-QFORM 10-QNov 14, 2025
- 8-KFORM 8-KNov 13, 2025
- 8-KFORM 8-KNov 12, 2025
- S-3FORM S-3Nov 7, 2025
- 8-KFORM 8-KOct 23, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2025 | Q3 2025 | $0.00 | — | +0% |
| Two Sigma Investments | Q2 2025 | Q3 2025 | $0.00 | — | +0% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.